Header Logo

Mervyn Mer

Concepts (279)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Sepsis
13
2024
102
3.730
Why?
Critical Care
19
2025
52
3.480
Why?
Critical Illness
9
2025
44
3.270
Why?
Intensive Care Units
17
2025
66
2.980
Why?
Developing Countries
6
2025
400
1.300
Why?
Humans
58
2025
14537
1.260
Why?
Fluid Therapy
8
2025
25
1.210
Why?
Infection Control
4
2021
31
1.120
Why?
Pandemics
6
2022
296
1.100
Why?
Shock, Septic
5
2024
10
1.090
Why?
Pneumonia, Viral
4
2020
104
1.080
Why?
Practice Guidelines as Topic
8
2021
127
1.070
Why?
Health Resources
5
2024
66
1.050
Why?
Anti-Bacterial Agents
6
2024
293
1.030
Why?
Coronavirus Infections
3
2020
71
0.970
Why?
Lymphohistiocytosis, Hemophagocytic
1
2021
1
0.780
Why?
Consensus
4
2024
62
0.740
Why?
Inflammation
1
2021
104
0.740
Why?
Malaria
3
2020
213
0.730
Why?
Tertiary Care Centers
2
2021
80
0.720
Why?
Quality Improvement
1
2020
34
0.700
Why?
Intensive Care Units, Neonatal
2
2019
17
0.570
Why?
Healthcare Disparities
1
2017
43
0.550
Why?
Hemoglobins
1
2016
40
0.530
Why?
Survival Rate
2
2016
96
0.530
Why?
Hospital Mortality
1
2016
95
0.530
Why?
Betacoronavirus
3
2020
52
0.520
Why?
Patient Discharge
1
2016
27
0.520
Why?
Drug Resistance, Bacterial
2
2017
135
0.510
Why?
Hospitalization
3
2021
418
0.500
Why?
Infant, Newborn, Diseases
1
2016
73
0.500
Why?
Antitubercular Agents
1
2018
322
0.490
Why?
Health Services Needs and Demand
1
2015
57
0.480
Why?
Tuberculosis, Pulmonary
1
2018
324
0.470
Why?
Delphi Technique
3
2024
30
0.470
Why?
Oxygen
4
2023
25
0.450
Why?
Anticoagulants
4
2025
57
0.420
Why?
Venous Thromboembolism
3
2025
27
0.420
Why?
Tuberculosis
1
2018
543
0.400
Why?
Microbial Sensitivity Tests
2
2019
198
0.400
Why?
Ceftriaxone
1
2012
13
0.390
Why?
Randomized Controlled Trials as Topic
3
2024
244
0.390
Why?
Bacteria
1
2012
47
0.380
Why?
Lactic Acid
3
2025
34
0.330
Why?
Male
14
2025
6754
0.320
Why?
Drug Resistance, Multiple, Bacterial
2
2019
37
0.320
Why?
South Africa
11
2021
7596
0.320
Why?
Silver Sulfadiazine
1
2008
1
0.310
Why?
Catheterization, Central Venous
1
2008
2
0.310
Why?
Chlorhexidine
1
2008
10
0.310
Why?
Anti-Infective Agents, Local
1
2008
16
0.310
Why?
Adult
13
2024
5913
0.290
Why?
Female
15
2025
9103
0.290
Why?
Infant, Newborn
5
2019
1479
0.280
Why?
Heparin, Low-Molecular-Weight
2
2025
11
0.270
Why?
Oxygen Inhalation Therapy
3
2023
13
0.270
Why?
Aged
6
2020
1740
0.270
Why?
Middle Aged
10
2020
3601
0.260
Why?
Research Design
3
2021
124
0.260
Why?
Drug Administration Routes
3
2021
8
0.250
Why?
Infant
5
2018
2244
0.250
Why?
Nutrition Therapy
1
2025
4
0.240
Why?
Drug Administration Schedule
3
2021
156
0.240
Why?
Acetates
1
2025
7
0.240
Why?
Infectious Disease Transmission, Patient-to-Professional
2
2021
11
0.240
Why?
Palliative Care
1
2024
52
0.230
Why?
Respiratory Insufficiency
2
2021
17
0.230
Why?
Terminal Care
1
2024
35
0.230
Why?
Nutritional Status
1
2025
76
0.230
Why?
Child
4
2018
2242
0.220
Why?
Retrospective Studies
6
2019
799
0.220
Why?
Attitude of Health Personnel
1
2025
106
0.220
Why?
Health Personnel
2
2022
231
0.210
Why?
Pneumonia
1
2024
131
0.210
Why?
Enterobacteriaceae
2
2019
11
0.210
Why?
Risk Factors
5
2021
1475
0.210
Why?
Global Health
2
2024
193
0.200
Why?
Resuscitation
2
2021
18
0.200
Why?
Advisory Committees
2
2018
14
0.190
Why?
Chemokines
1
2021
9
0.190
Why?
Aged, 80 and over
2
2016
468
0.190
Why?
Antimicrobial Stewardship
2
2019
14
0.190
Why?
Candidemia
1
2021
13
0.190
Why?
Thrombocytopenia
1
2021
11
0.190
Why?
Erythrocyte Transfusion
2
2021
6
0.190
Why?
Cytokines
1
2021
107
0.180
Why?
Communicable Diseases
2
2019
62
0.180
Why?
Oxygenators
1
2020
2
0.180
Why?
Thrombosis
1
2021
47
0.180
Why?
Hospital Administration
1
2020
3
0.180
Why?
Cross-Sectional Studies
4
2019
1422
0.180
Why?
Clinical Protocols
1
2020
26
0.180
Why?
Young Adult
4
2018
2498
0.180
Why?
Renal Dialysis
1
2020
27
0.180
Why?
Adolescent
5
2018
2985
0.180
Why?
Lung Diseases, Obstructive
1
2000
5
0.180
Why?
Clinical Trials as Topic
1
2021
112
0.180
Why?
Prospective Studies
5
2021
1160
0.180
Why?
Child, Preschool
4
2018
1748
0.170
Why?
Home Care Services
1
2000
15
0.170
Why?
Infant, Very Low Birth Weight
2
2019
21
0.170
Why?
Mucormycosis
1
2019
3
0.170
Why?
Health Priorities
1
2020
62
0.170
Why?
Dose-Response Relationship, Drug
3
2015
125
0.160
Why?
Neonatal Sepsis
1
2019
29
0.160
Why?
Severity of Illness Index
4
2021
253
0.160
Why?
Anti-Infective Agents
3
2021
57
0.160
Why?
Expert Testimony
1
2018
2
0.160
Why?
Cause of Death
2
2019
221
0.160
Why?
Shock
1
2018
4
0.160
Why?
Chickenpox
1
1998
2
0.160
Why?
Patient Care Bundles
1
2018
6
0.160
Why?
Inservice Training
1
2018
7
0.150
Why?
Family
1
2018
35
0.150
Why?
Glucocorticoids
1
1998
20
0.150
Why?
Surveys and Questionnaires
3
2025
563
0.150
Why?
Nicotinamide Phosphoribosyltransferase
1
2018
3
0.150
Why?
Calcium-Binding Proteins
1
2018
4
0.150
Why?
Nerve Tissue Proteins
1
2018
18
0.150
Why?
DNA-Binding Proteins
1
2018
20
0.150
Why?
Emergency Service, Hospital
1
2018
38
0.150
Why?
Klebsiella
2
2019
6
0.140
Why?
Escherichia coli
2
2019
30
0.140
Why?
Severe Dengue
1
2016
1
0.140
Why?
Patient Admission
1
2016
11
0.140
Why?
Blood Substitutes
1
2016
2
0.140
Why?
Product Surveillance, Postmarketing
1
2016
2
0.140
Why?
Organ Dysfunction Scores
3
2021
3
0.140
Why?
Cattle
1
2016
28
0.140
Why?
Reproducibility of Results
2
2021
217
0.140
Why?
Atherosclerosis
1
2018
100
0.130
Why?
Respiration, Artificial
3
2021
47
0.130
Why?
Poverty
1
2017
152
0.130
Why?
Health Care Costs
1
2017
115
0.130
Why?
Arthritis, Rheumatoid
1
2018
158
0.130
Why?
Birth Weight
1
2016
80
0.130
Why?
Africa South of the Sahara
1
2016
353
0.120
Why?
Internationality
2
2025
36
0.120
Why?
Incidence
2
2015
685
0.120
Why?
Population Surveillance
1
2016
325
0.120
Why?
Animals
1
2016
1081
0.110
Why?
Diagnosis, Differential
3
2021
63
0.110
Why?
Vena Cava Filters
1
2013
4
0.110
Why?
Preoperative Care
1
2013
9
0.110
Why?
Cross Infection
2
2006
52
0.110
Why?
Secondary Prevention
1
2013
20
0.110
Why?
HIV Infections
2
2021
5097
0.100
Why?
Hospitals, Private
1
2012
8
0.100
Why?
Hemorrhage
1
2013
72
0.100
Why?
Physicians
2
2025
31
0.100
Why?
Citrobacter
1
2012
1
0.100
Why?
Viridans Streptococci
1
2012
1
0.100
Why?
Practice Patterns, Physicians'
1
2012
43
0.100
Why?
Societies, Medical
2
2024
26
0.100
Why?
Immunoglobulins
2
2021
11
0.100
Why?
Bacterial Infections
1
2012
54
0.100
Why?
Electronic Health Records
2
2021
10
0.100
Why?
Reference Values
2
2021
64
0.100
Why?
Haemophilus influenzae
1
2012
42
0.100
Why?
Staphylococcus aureus
1
2012
43
0.100
Why?
Time-to-Treatment
2
2021
42
0.090
Why?
Arterial Pressure
2
2021
35
0.090
Why?
Symptom Assessment
2
2020
16
0.090
Why?
Heparin
1
2010
5
0.090
Why?
Biomarkers
2
2021
327
0.090
Why?
Asthma
1
2010
33
0.090
Why?
Patient Education as Topic
2
2007
48
0.080
Why?
Blood Glucose
2
2021
107
0.080
Why?
Rwanda
2
2018
30
0.080
Why?
Evidence-Based Medicine
2
2018
34
0.080
Why?
Hospitals, Special
1
2007
4
0.070
Why?
Health Services Accessibility
2
2020
280
0.070
Why?
Thromboembolism
1
2007
10
0.070
Why?
Feasibility Studies
2
2018
101
0.070
Why?
Warfarin
1
2007
19
0.070
Why?
Double-Blind Method
1
2008
272
0.070
Why?
Cost-Benefit Analysis
2
2017
253
0.070
Why?
Disease Management
2
2019
74
0.070
Why?
Treatment Outcome
2
2018
889
0.060
Why?
Communicable Disease Control
1
2006
101
0.060
Why?
Anesthesiologists
1
2025
1
0.060
Why?
Buffers
1
2025
1
0.060
Why?
Isotonic Solutions
1
2025
6
0.060
Why?
Europe
1
2024
56
0.060
Why?
Communication
1
2024
57
0.060
Why?
Decision Making
1
2024
53
0.060
Why?
Databases, Factual
1
2024
64
0.060
Why?
Income
1
2024
85
0.060
Why?
Vasoconstrictor Agents
1
2021
6
0.050
Why?
Cardiotonic Agents
1
2021
8
0.050
Why?
Renal Replacement Therapy
1
2021
6
0.050
Why?
Personal Protective Equipment
1
2021
16
0.050
Why?
Hemodynamics
1
2021
32
0.050
Why?
Multiple Organ Failure
1
2021
4
0.050
Why?
Dyspnea
1
2021
10
0.050
Why?
Recovery of Function
1
2021
11
0.050
Why?
Equipment Reuse
1
2020
2
0.050
Why?
Blood Physiological Phenomena
1
2020
3
0.050
Why?
Equipment Design
1
2020
27
0.050
Why?
Partial Pressure
1
2000
1
0.040
Why?
Vital Capacity
1
2000
6
0.040
Why?
Forced Expiratory Volume
1
2000
9
0.040
Why?
Models, Biological
1
2020
77
0.040
Why?
Ebolavirus
1
2000
4
0.040
Why?
Hemorrhagic Fever, Ebola
1
2000
9
0.040
Why?
Lung
1
2000
70
0.040
Why?
Proteus mirabilis
1
2019
2
0.040
Why?
Serratia marcescens
1
2019
3
0.040
Why?
Enterobacter cloacae
1
2019
3
0.040
Why?
Carbapenem-Resistant Enterobacteriaceae
1
2019
6
0.040
Why?
Africa
1
2021
376
0.040
Why?
Patient Compliance
1
2000
120
0.040
Why?
Infant, Premature
1
2019
56
0.040
Why?
Klebsiella pneumoniae
1
2019
39
0.040
Why?
Disease Outbreaks
1
2000
111
0.040
Why?
Carbapenems
1
2019
17
0.040
Why?
Central Venous Pressure
1
2018
2
0.040
Why?
Monitoring, Physiologic
1
2018
25
0.040
Why?
Professional-Family Relations
1
2018
4
0.040
Why?
Blood Gas Analysis
1
1998
3
0.040
Why?
Heart Rate
1
2018
32
0.040
Why?
Herpesvirus 3, Human
1
1998
3
0.040
Why?
Diagnostic Techniques and Procedures
1
2018
4
0.040
Why?
Body Temperature
1
2018
7
0.040
Why?
Controlled Before-After Studies
1
2018
1
0.040
Why?
Blood Transfusion
1
2018
13
0.040
Why?
Acyclovir
1
1998
11
0.040
Why?
Medically Underserved Area
1
2018
13
0.040
Why?
Hospitals, District
1
2018
5
0.040
Why?
Patient Safety
1
2018
9
0.040
Why?
Length of Stay
1
2018
43
0.040
Why?
Radiography
1
1998
80
0.040
Why?
Acute Disease
1
2018
105
0.040
Why?
Matrix Metalloproteinase 2
1
2018
11
0.040
Why?
Carotid Arteries
1
2018
19
0.040
Why?
Drug Resistance, Multiple
1
2017
6
0.040
Why?
Gene Expression Regulation
1
2018
40
0.040
Why?
Rheumatoid Factor
1
2018
16
0.040
Why?
Plaque, Atherosclerotic
1
2018
27
0.040
Why?
Delivery of Health Care
1
2021
239
0.040
Why?
Glomerular Filtration Rate
1
2018
62
0.040
Why?
Drug Therapy, Combination
1
1998
279
0.040
Why?
Antiviral Agents
1
1998
111
0.040
Why?
Carotid Intima-Media Thickness
1
2018
108
0.040
Why?
Global Burden of Disease
1
2017
5
0.040
Why?
Drug Resistance
1
2017
35
0.040
Why?
Quality of Health Care
1
2017
62
0.030
Why?
Antimalarials
1
2016
33
0.030
Why?
Biomedical Research
1
2017
49
0.030
Why?
Socioeconomic Factors
1
2018
411
0.030
Why?
Malaria, Falciparum
1
2016
39
0.030
Why?
Blood Pressure
1
2018
317
0.030
Why?
Body Mass Index
1
2018
321
0.030
Why?
Lupus Erythematosus, Systemic
1
1996
35
0.030
Why?
Cohort Studies
1
2019
967
0.030
Why?
Dabigatran
1
2013
3
0.030
Why?
beta-Alanine
1
2013
3
0.030
Why?
Thiophenes
1
2013
4
0.030
Why?
Rivaroxaban
1
2013
6
0.030
Why?
Morpholines
1
2013
5
0.030
Why?
Benzimidazoles
1
2013
13
0.030
Why?
International Normalized Ratio
1
2013
17
0.030
Why?
Drug Substitution
1
2013
33
0.030
Why?
Chemoprevention
1
2013
33
0.030
Why?
Drug Monitoring
1
2013
55
0.030
Why?
Drug Prescriptions
1
2012
9
0.030
Why?
Drug Resistance, Microbial
1
2012
26
0.030
Why?
Risk Assessment
1
2013
225
0.020
Why?
Hospitals, Public
1
2012
45
0.020
Why?
Guideline Adherence
1
2012
43
0.020
Why?
Time Factors
1
2013
507
0.020
Why?
Drug Delivery Systems
1
2013
252
0.020
Why?
Medicine in the Arts
1
2009
3
0.020
Why?
Case-Control Studies
1
2010
480
0.020
Why?
Prevalence
1
2012
1192
0.020
Why?
Pregnancy
1
2007
1862
0.010
Why?
Fatal Outcome
1
2000
21
0.010
Why?
APACHE
1
1996
12
0.010
Why?
Prognosis
1
1996
199
0.010
Why?
Mer's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (279)
Explore
_
Co-Authors (15)
Explore
_
Similar People (60)
Explore
_